These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12755840)

  • 21. Preliminary report on the use of oral tacrolimus (FK506) in the treatment of complicated proximal small bowel and fistulizing Crohn's disease.
    Sandborn WJ
    Am J Gastroenterol; 1997 May; 92(5):876-9. PubMed ID: 9149205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical tacrolimus therapy for antibiotic-refractory pouchitis.
    Uchino M; Ikeuchi H; Matsuoka H; Bando T; Hida N; Nakamura S; Takesue Y; Tomita N
    Dis Colon Rectum; 2013 Oct; 56(10):1166-73. PubMed ID: 24022534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral tacrolimus for steroid-dependent and steroid-resistant ulcerative colitis in children.
    Ziring DA; Wu SS; Mow WS; Martín MG; Mehra M; Ament ME
    J Pediatr Gastroenterol Nutr; 2007 Sep; 45(3):306-11. PubMed ID: 17873742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk-benefit assessment of drugs used in the treatment of inflammatory bowel disease.
    Hanauer SB; Stathopoulos G
    Drug Saf; 1991; 6(3):192-219. PubMed ID: 1676590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tacrolimus as rescue therapy for steroid-dependent/steroid-refractory ulcerative colitis: Experience from tertiary referral center in India.
    Sud S; Sachdeva S; Puri AS
    Indian J Gastroenterol; 2021 Dec; 40(6):598-603. PubMed ID: 34971402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral tacrolimus for the treatment of refractory inflammatory bowel disease in the biologic era.
    Thin LW; Murray K; Lawrance IC
    Inflamm Bowel Dis; 2013 Jun; 19(7):1490-8. PubMed ID: 23615528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short-term efficacy of tacrolimus in steroid-refractory ulcerative colitis - experience in 130 patients.
    Schmidt KJ; Herrlinger KR; Emmrich J; Barthel D; Koc H; Lehnert H; Stange EF; Fellermann K; Büning J
    Aliment Pharmacol Ther; 2013 Jan; 37(1):129-36. PubMed ID: 23121200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy of oral tacrolimus in patients with moderate/severe ulcerative colitis not receiving concomitant corticosteroid therapy.
    Inoue T; Murano M; Narabayashi K; Okada T; Nouda S; Ishida K; Kawakami K; Abe Y; Takeuchi T; Tokioka S; Umegaki E; Higuchi K
    Intern Med; 2013; 52(1):15-20. PubMed ID: 23291669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tacrolimus: a new immunosuppressant for steroid refractory inflammatory bowel disease.
    Fellermann K; Herrlinger KR; Witthoeft T; Homann N; Ludwig D; Stange EF
    Transplant Proc; 2001 May; 33(3):2247-8. PubMed ID: 11377517
    [No Abstract]   [Full Text] [Related]  

  • 30. [Sweet syndrome and erythema nodosum in ulcerative colitis, refractory to steroids: successful treatment with tacrolimus].
    Fellermann K; Rudolph B; Witthöft T; Herrlinger KR; Tronnier M; Ludwig D; Stange EF
    Med Klin (Munich); 2001 Feb; 96(2):105-8. PubMed ID: 11253280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunodulation with tacrolimus (FK506): results of a prospective, open-label, non-controlled trial in patients with inflammatory bowel disease.
    de Oca J; Vilar L; Castellote J; Sánchez Santos R; Parés D; Biondo S; Osorio A; del Rio C; Jaurrieta E; Martí Ragué J
    Rev Esp Enferm Dig; 2003 Jul; 95(7):465-70, 459-64. PubMed ID: 14515846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
    Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J
    Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tacrolimus induction followed by maintenance monotherapy is useful in selected patients with moderate-to-severe ulcerative colitis refractory to prior treatment.
    Boschetti G; Nancey S; Moussata D; Stefanescu C; Roblin X; Chauvenet M; Stroeymeyt K; Bouhnik Y; Flourié B
    Dig Liver Dis; 2014 Oct; 46(10):875-80. PubMed ID: 25023007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term Outcomes in Steroid-refractory Ulcerative Colitis Treated with Tacrolimus Alone or in Combination with Purine Analogues.
    Schmidt KJ; Müller N; Dignass A; Baumgart DC; Lehnert H; Stange EF; Herrlinger KR; Fellermann K; Büning J
    J Crohns Colitis; 2016 Jan; 10(1):31-7. PubMed ID: 26419459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Tacrolimus in the treatment of refractory moderate-to-severe inflammatory bowel disease].
    Olmedo Martín R; Jiménez Pérez M; Marín García D; Amo Trillo V; Pérez-Olivares Jaén J; Romero Blasco B
    Gastroenterol Hepatol; 2006; 29(6):327-33. PubMed ID: 16790180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Previous exposure to biologics and C-reactive protein are associated with the response to tacrolimus in inflammatory bowel disease.
    Rodríguez-Lago I; Merino O; Nantes Ó; Muñoz C; Aguirre U; Cabriada JL
    Rev Esp Enferm Dig; 2016 Sep; 108(9):550-7. PubMed ID: 27604685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cyclosporin A therapy in steroid-refractory patients with chronic inflammatory bowel diseases].
    Dejaco C; Gasché C; Reinisch W; Moser G; Novacek G; Tillinger W; Vogelsang H; Gangl A
    Wien Klin Wochenschr; 1998 Sep; 110(16):579-84. PubMed ID: 9782579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus.
    Yamamoto S; Nakase H; Matsuura M; Honzawa Y; Masuda S; Inui K; Chiba T
    J Gastroenterol Hepatol; 2010 May; 25(5):886-91. PubMed ID: 20546441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tacrolimus Therapy in Steroid-Refractory Ulcerative Colitis: A Review.
    Wu B; Tong J; Ran Z
    Inflamm Bowel Dis; 2020 Jan; 26(1):24-32. PubMed ID: 30980713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficacy and safety of cyclosporine in the treatment of inflammatory bowel disease in children - a retrospective study].
    Socha P; Wawer Z; Ryzko J; Orłowska E; Szczepański M; Kierkus J; Celińska-Cedro D; Socha J
    Med Wieku Rozwoj; 2006; 10(2):429-35. PubMed ID: 16825713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.